Abstract
Background
Sarcopenia, defined as low muscle mass (LMM), and dynapenia have been associated with adverse outcomes in elderly.
Objective
Contrast the association of sarcopenia versus dynapenia with incidence of disability.
Design p]A four-year prospective study (2006–2010)
Setting
São Paulo, Brazil.
Participants
478 individuals aged 60 and older from the Saúde, Bem-Estar e Envelhecimento (SABE) study who were non-disabled at baseline.
Measurements
Sarcopenia, measured according to the European Working Group on Sarcopenia in Older People (EWGSOP), includes: LMM assessed by skeletal muscle mass index ≤8.90kg/m2 (men) and ≤6.37kg/m2 (women); low muscle strength (LMS) assessed by handgrip strength <30kg (men) and <20kg (women); and low physical performance (LPP) assessed by gait speed ≤0.8m/s. Diagnosis of sarcopenia required LMM plus LMS or LPP. Dynapenia was defined as handgrip strength <30kg (men) and <20kg (women). Covariates included socio-demographic and behavioral variables, medical conditions, hospitalization, depressive symptoms, cognition, perception of vision, hearing and body mass index.
Outcomes
Disability in mobility or instrumental activities of daily living (IADL) or disability in activities of daily living (ADL) and IADL.
Results
The incidence density of mobility or IADL disability was 43.4/1000 person/year and 22.6/1000 person/year for IADL and ADL disability. There was no significant difference in incidence density according sarcopenia or dynapenia status. After controlling for all covariates, sarcopenia was associated with mobility or IADL disability (relative risk ratio = 2.23, 95%Confidence Interval: 1.03–4.85). Dynapenia was not associated with disability.
Conclusions
Sarcopenia according to the EWGSOP definition can be used in clinical practice as a screening tool for early functional decline (mobility or IADL disability).
Similar content being viewed by others
References
Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci 1995;50A:5–8.
Roubenoff R, Hughes VA. Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci 2000;55A(12):M716–M724.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Age and Ageing 2010;39:412–423.
Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care 2010;13(3):271–276.
Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci 2012;12;67A(1):28–40.
Landi F, Cruz-Jentoft AJ, Liperoti R et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age and Ageing 2013;42(2):203–209.
Katz S, Jaffe MW, Ford AB, et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963;185(12):914–919.
Hughes SL, Edelman PL, Singer RH, et al. Joint impairment and self-reported disability in elderly persons. J Gerontol 1993;48:S84–S92.
Dunlop DD, Hughes SL, Manheim LM. Disability in activities of daily living: patterns of change and a hierarchy of disability. Am J Pub Health 1997;87:378–383.
Stuck AE, Walthert JM, Nikolaus T, et al. Risk factors for functional status decline in community-living elderly people: A systematic literature review. Soc Sci Med 1999;48:445–469.
Guralnik JM, Simonsick EM. Physical disability in older Americans. J Gerontol A Biol Sci Med Sci 1993;48:3–10.
Lawton MP. The functional assessment of elderly people. J Am Geriatr Soc 1971;19(6):465–481.
Ottenbacher KJ, Ostir GV, Peek MK et al. Frailty in older Mexican Americans. J Am Geriatr Soc 2005;53:1524–1531.
Guttman LA. The basis for scalogram analysis. In Stouffer SA, Guttman LA. Schuman EA. Measurement and prediction. Volume 4 of Studies in social psychology in world war II. Princeton: Princeton University Press, 1950.
Ramos RL, Perracini M, Rosa TE et al. Significance and management of disability among urban elderly residents in Brazil. Journal of Cross-Cultural Gerontology 1993;8:313–323.
Lee RC, Wang Z, Heo M et al. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 2000;72:796–803.
Rech CR, Dellagrana RA, Marucci MFN et al. Validity of anthropometric equations for the estimation of muscle mass in elderly. Braz J Kineant 2012;14(1):23–31.
Delmonico MJ, Harris TB, Lee JS et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007;55:769–774.
Newman AB, Kupelian V, Visser M et al. Sarcopenia: Alternative definitios and associations with lower extremity function. J Am Geriatr Soc 2003;51:1602–1609.
Laurentani F, Russo C, Bandinelli S et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003;95:1851–1860.
Guralnik JM, Simonsick EM, Ferruci L et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49(2):M85–M94.
Guedes DP, Lopes CC, Guedes JERP. Reprodutibilidade e validade do Questionário Internacional de Atividade Física em adolescentes. Rev Bras Med Esp 2005;11(2):151–157.
Craig CL, Marshall AL, Sjostrom M et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Spor Exe 2003;35:1381–1395.
Folstein MF, Folstein SE, Mchugh PR. A practical method for grading the cognitive state of patient for the clinician. J Psych Res 1975;12:189–198.
Icaza MC, Albala C. PROJETO SABE. Minimental State Examination (MMSE) del Studio de dementia en Chile: Análisis estadístico. OPAS, 1999;1–18.
Almeida OP, Almeida SA. Short versions of the Geriatric Depression Scale: A Study of their validity for the diagnosis of a major depressive episode according to ICD-10 e DSM-IV. Inter J Geriatric Psych 1999;14:858–865.
Alexandre TS, Corona LP, Nunes DP et al. Gender differences in incidence and determinants of disability in activities of daily living among elderly individuals: SABE Study. Arch Gerontol Geriatr 2012; 55:431–437.
Janssen I. Influence of sarcopenia on the development of physical disability: The Cardiovascular Health Study. J Am Geriatr Soc 2006;54:56–62.
Rantanen T, Guralnik JM, Foley D et al. Midlife hand grip strength as a predictor of old age disability. JAMA 1999;281(6):558–560.
Al Snih S, Markides K, Ottenbacher KJ, Raji MA. Hand grip strength and incident ADL disability in elderly Mexican Americans over a seven-year period. Aging Clinical and Experimental Research 2004;16(6):481–486.
Abellan Van Kan G, Rolland Y, Andrieu S et al. Gait speed at usual pace as a predictor of adverse outcomes in community dwelling older people an international academy on nutrition and aging (IANA) task force. The Journal of Nutrition, Health & Aging 2009;13(10):881–889.
Tanimoto Y, Watanabe M, Sun W et al. Association between sarcopenia and higher level functional capacity in daily living in community-dwelling elderly subjects in Japan. Arch Gerontol Geriatric 2012;55:e9–el3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Silva Alexandre, T., De Oliveira Duarte, Y.A., Ferreira Santos, J.L. et al. Sarcopenia according to the European Working Group on Sarcopenia in older people (EWGSOP) versus dynapenia as a risk factor for disability in the elderly. J Nutr Health Aging 18, 547–553 (2014). https://doi.org/10.1007/s12603-014-0465-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-014-0465-9